Circulating tumor cells (CTCs) are rare cells detach from a primary tumor and circulate to other parts of the body causes metastasis. CTC are detected and quantified in 10 ml patient blood. CTC-count is an independent prognostic marker, indication of the aggressiveness of cancer. IGnomix CTC Count test is non invasive blood test which finds CTCs present in the blood and helps physicians in assessing the prognosis of metastatic tumors.